BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design
Top Cited Papers
- 31 August 2000
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (19) , 3482-3486
- https://doi.org/10.1021/jm0002679
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Influenza virus neuraminidase inhibitorsThe Lancet, 2000
- Dihydropyrancarboxamides Related to Zanamivir: A New Series of Inhibitors of Influenza Virus Sialidases. 2. Crystallographic and Molecular Modeling Study of Complexes of 4-Amino-4H-pyran-6-carboxamides and Sialidase from Influenza Virus Types A and BJournal of Medicinal Chemistry, 1998
- Three-dimensional Structure of Influenza A N9 Neuraminidase and Its Complex with the Inhibitor 2-Deoxy 2,3-Dehydro-N-Acetyl Neuraminic AcidJournal of Molecular Biology, 1993
- Rational design of potent sialidase-based inhibitors of influenza virus replicationNature, 1993
- Clinical and epidemiological importance of influenza a viruses resistant to amantadine and rimantadineReviews in Medical Virology, 1992
- Protection against lethal influenza with neuraminidaseVirology, 1988
- Uptake, Metabolism and Excretion of Orally and Intravenously Administered, Double‐Labeled N‐GIycoloylneuraminic Acid and Single‐Labeled 2‐Deoxy‐2,3–dehydro‐N‐acetylneuraminic Acid in Mouse and RatEuropean Journal of Biochemistry, 1982
- SERIOUS MORBIDITY AND MORTALITY ASSOCIATED WITH INFLUENZA EPIDEMICSEpidemiologic Reviews, 1982
- Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-d-N-acetylneuraminate) substrateAnalytical Biochemistry, 1979
- Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acidVirology, 1974